Chinese pharma stocks fall after Trump links Tylenol to autism
NegativeFinancial Markets

Chinese pharmaceutical stocks have taken a hit following comments made by former President Donald Trump, who linked the pain reliever Tylenol to autism. This statement has raised concerns among investors about potential regulatory scrutiny and public perception, leading to a decline in stock prices. The implications of such claims can significantly impact the pharmaceutical industry, especially in China, where companies are already navigating a complex market.
— Curated by the World Pulse Now AI Editorial System